Security · for the CIO conversation
The architecture is the trust signal.
Most analytics tools ask pharma to move sensitive commercial data into their cloud. PharmaOS does not move it at all. The default is zero-persistence: queries run, answers return, nothing is retained.
Data flow
Your data does not make a round trip.
It is read where it lives, analyzed in memory, and the working set is discarded with the session.
Your stack
CRM and BI, in your environment (Power BI, your warehouse).
PharmaOS compute
Reads, analyzes, answers in memory. Nothing is written to a PharmaOS store.
The answer
Returned to the user. The working set is discarded.
No path writes client data back to a PharmaOS store.
Deployment
Two ways to run it. Neither stores your data.
SaaS, zero-persistence
Default- Queries execute in memory; no client data retained server-side
- No data lake, no training on your data, no warm cache of results
- Fastest to stand up; nothing to provision on your side
Private / on-prem
Enterprise- Runs inside your VPC or on-prem; data never leaves your perimeter
- Your network controls, your identity provider, your audit logging
- For organizations where data residency is contractual, not optional
Compliance posture
The short answers your CIO will ask for.
Data at rest
None by default. Zero-persistence is the architecture, not a setting.
Data in transit
Encrypted end to end between your stack and the compute layer.
Access
Scoped to division and brand; mapped to your identity provider.
Training
Your commercial data is never used to train shared models.
Bring your hardest security question.
We will walk your team through the architecture and the deployment that fits your data-residency requirements.